GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (OTCPK:CNVVY) » Definitions » PEG Ratio

CNVVY (ConvaTec Group) PEG Ratio : 27.61 (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is ConvaTec Group PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, ConvaTec Group's PE Ratio without NRI is 22.09. ConvaTec Group's 5-Year EBITDA growth rate is 0.80%. Therefore, ConvaTec Group's PEG Ratio for today is 27.61.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for ConvaTec Group's PEG Ratio or its related term are showing as below:

CNVVY' s PEG Ratio Range Over the Past 10 Years
Min: 1.8   Med: 10.8   Max: 33.27
Current: 27.61


During the past 11 years, ConvaTec Group's highest PEG Ratio was 33.27. The lowest was 1.80. And the median was 10.80.


CNVVY's PEG Ratio is ranked worse than
96.84% of 253 companies
in the Medical Devices & Instruments industry
Industry Median: 1.92 vs CNVVY: 27.61

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


ConvaTec Group PEG Ratio Historical Data

The historical data trend for ConvaTec Group's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group PEG Ratio Chart

ConvaTec Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.91 14.82 - - 28.10

ConvaTec Group Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 28.10 -

Competitive Comparison of ConvaTec Group's PEG Ratio

For the Medical Instruments & Supplies subindustry, ConvaTec Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ConvaTec Group's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's PEG Ratio distribution charts can be found below:

* The bar in red indicates where ConvaTec Group's PEG Ratio falls into.



ConvaTec Group PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

ConvaTec Group's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=22.089552238806/0.80
=27.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


ConvaTec Group  (OTCPK:CNVVY) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


ConvaTec Group PEG Ratio Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ConvaTec Group Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

ConvaTec Group Headlines

From GuruFocus

Full Year 2018 ConvaTec Group PLC Earnings Call Transcript

By GuruFocus Research 02-13-2024

Vanguard Health Care Fund Gains 5 New Stocks

By Sydnee Gatewood Sydnee Gatewood 02-01-2017

Half Year 2023 ConvaTec Group PLC Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2022 ConvaTec Group PLC Earnings Call Transcript

By GuruFocus Research 02-13-2024